Clinical trial
Comparison of the Efficacy of Mycophenolate Mofetil Combined With Methotrexate and Cyclophosphamide for the Treatment of Takayasu's Arteritis
NCT03096275 is registered in ClinicalTrials.gov with Chinese SLE Treatment And Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy of Mycophenolate Mofetil Combined With Methotrexate and Cyclophosphamide for the Treatment of Takayasu's Arteritis
- Lead sponsor
- Chinese SLE Treatment And Research Group
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 16, 2017
- Completion date
- November 11, 2022
- Enrollment
- 138 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.